Gilder Gagnon Howe & CO LLC Revance Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

  • $7.87 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$24.7 - $37.61 $39,668 - $60,401
1,606 Added 2.89%
57,123 $1.45 Million
Q1 2023

May 15, 2023
BUY
$18.36 - $35.27 $47,332 - $90,926
2,578 Added 4.87%
55,517 $1.79 Million
Q4 2022

Feb 14, 2023
SELL
$18.32 - $30.66 $54 - $91
-3 Reduced 0.01%
52,939 $977,000
Q3 2022

Nov 14, 2022
BUY
$14.33 - $28.47 $758,658 - $1.51 Million
52,942 New
52,942 $1.43 Million

Others Institutions Holding RVNC

# of Institutions
234
Shares Held
82.8M
Call Options Held
680K
Put Options Held
896K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email